Table 1.

Effects of bezafibrate, quinazolinone and its halogenated derivatives on relative liver weights of rats with single and combined hypercholesterolemia compared to normal controls.

Single Hypercholesterolemia		Combined Hypercholesterolemia
Groups	Liver wt./b.wt.	Groups	Liver wt./b.wt.
N.C		N.C
Mean ± SD	0.031 ± 0.005	Mean ± SD	0.031 ± 0.005
Range	(0.024–0.039)	Range	(0.024–0.039)
HCD+B		C+B
Mean ± SD	0.030 ± 0.003	Mean ± SD	0.037 ± 0.005
Range	(0.025–0.032)	Range	(0.032–0.045)
Change%	-11.76	Change%	5.71
HCD+Q		C+Q
Mean ± SD	0.033 ± 0.003	Mean ± SD	0.030 ± 0.002
Range	(0.029–0.037)	Range	(0.028–0.033)
Change%	-2.94	Change%	-14.29
HCD+BrQ		C+BrQ
Mean ± SD	0.031 ± 0.003	Mean ± SD	0.029 ± 0.003
Range	(0.028–0.035)	Range	(0.025–0.036)
Change%	-8.82	Change%	-17.14
HCD+IQ		C+IQ
Mean ± SD	0.030 ± 0.002	Mean ± SD	0.030 ± 0.001
Range	(0.027–0.032)	Range	(0.027–0.031)
Change%	-11.76	Change%	-14.29